Efficacy and Clinical Characteristics of Liraglutide in Japanese Patients With Type 2 Diabetes

BACKGROUND: Liraglutide was first released in Japan as a long-acting once-daily glucagon-like peptide-1 receptor agonist. The maximum dose in Japan is 0.9 mg/day, which is half of that used in the United States and the European Union (1.8 mg/day). The efficacy of this maximum allowable dose of lirag...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Clin Med Res
Main Authors: Ito, Daisuke, Iuchi, Takujiro, Kurihara, Susumu, Inoue, Ikuo, Katayama, Shigehiro, Inukai, Kouichi
Format: Artigo
Sprog:Inglês
Udgivet: Elmer Press 2015
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4522987/
https://ncbi.nlm.nih.gov/pubmed/26251684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2237w
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker